Radiofrequency Ablation Combined With Transcatheter Arterial Chemoembolization Versus Re-resection for Recurrent Hepatocellular Carcinoma
Interventional
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
overall survival
5 year
No
minshan chen, M.D.
Principal Investigator
Department of Hepatobiliary Surgery, Sun Yat-sen University Cancer Center
China: Ministry of Health
TACE+RFA VS. Re-resection
NCT01833286
July 2013
July 2019
Name | Location |
---|